APAC
Mylan’s Asia-Pacific (APAC) presence includes
market-leading positions in Australia and New Zealand, as well as a growing
presence in Japan, the world’s second largest pharmaceutical market. Mylan
maintains a full complement of capabilities in the region, from product
development and manufacturing, to marketing and distribution of both
prescription and over-the-counter medicines. Mylan's Asia-Pacific businesses
include Alphapharm, Mylan Seiyaku and Mylan New Zealand.